Resident 360 Study Plans on AMBOSS

Find all Resident 360 study plans on AMBOSS

Fast Facts

A brief refresher with useful tables, figures, and research summaries

Hematuria

The presence of blood in the urine can be categorized as gross (seen with the naked eye) or microscopic (seen on dipstick analysis and urine microscopy); it is often seen in isolation but can be seen in conjunction with proteinuria.

Classification

  • Gross/macroscopic hematuria: blood in the urine is visible to the naked eye

    • Etiologies include:

      • trauma

      • pseudohematuria due to pigments/dyes (e.g., from food or medication)

      • bladder irritation (hemorrhagic cystitis)

      • urinary tract infection (UTI)/infection (most common cause)

      • nephrolithiasis

      • glomerular disease (glomerulonephritis)

      • nutcracker syndrome (a vascular anomaly in which left renal vein is compressed, leading to gross hematuria and sometimes flank pain)

    • In one retrospective review of 158 patients who presented to a pediatric emergency department (ED) for gross hematuria, half had an identifiable cause and half of those with an underlying identifiable cause had UTI.

  • Microscopic hematuria: blood in the urine is only noted on microscopic analysis

    • Etiologies include:

      • acute infection

      • hypercalciuria

      • nephrolithiasis

      • glomerulonephritis (including postinfectious)

      • IgA nephropathy

      • Alport syndrome

      • thin basement membrane nephropathy

Evaluation

  • A thorough history and physical exam can provide clues to the underlying etiology.

    • History of exercise/trauma may reveal source of gross hematuria.

    • Symptoms of unilateral flank pain and renal colic may signify nephrolithiasis.

    • Dysuria, fevers, increased frequency of urination, or incontinence may signify UTI.

    • Terminal hematuria (gross hematuria at the end of the urinary stream) is almost always due to an extrarenal (ureter or bladder) source of bleeding.

    • Exposure to medications (e.g., phenazopyridine, cyclophosphamide, rifampin) may explain finding of gross hematuria.

    • Family history of hematuria or progressive deafness suggests thin basement membrane syndrome or Alport syndrome.

    • Recurrent episodes of gross hematuria marked by persistent microscopic hematuria is commonly seen in IgA nephropathy.

    • History of skin infection or sore throat should prompt evaluation for post-infectious glomerulonephritis.

  • If urinalysis produces a positive dipstick, also check protein.

  • Urine microscopy

    • If sample is centrifuged:

      • supernatant red + dipstick positive = myoglobinuria/hemoglobinuria (aka “blood without blood”)

      • supernatant red + dipstick negative = nonblood/dyes/medications/porphyria

      • pellet red = hematuria

  • Serum laboratory tests

    • Conduct initial screening with basic metabolic panel (BMP), plasma complement (C3 and C4), albumin, antistreptolysin O (ASO), and antinuclear antibodies (ANA)/anti-double-stranded DNA (dsDNA).

    • If clinical history is significant for acute glomerulonephritis, consider antineutrophil cytoplasmic antibodies (ANCA), glomerular basement membrane (GBM), and other autoimmune antibodies.

  • Urine laboratory tests

    • calcium-to-creatinine ratio and protein-to-creatinine ratio.

    • urine culture if symptoms are concerning for UTI

    • some viral infections (e.g., adenovirus) can also lead to gross hematuria

  • Imaging

    • ultrasound, CT, or MRI if there is concern for nutcracker syndrome

Management

Nephrolithiasis: Patients with nephrolithiasis typically require serial ultrasounds and referral to Urology for management of stone burden.

  • CT may be required to further characterize the stone burden prior to removal. A metabolic workup, including 24-hour urine collection, is then necessary to address the patient’s risk of forming new stones.

  • Dietary approaches to prevent stones include increasing liquid intake/hydration, limiting salt intake, and alkalinizing the urine with citrate.

  • Other approaches include a thiazide diuretic to limit calcium excretion in the urine.

  • Consider genetic testing for monogenic causes of nephrolithiasis that currently explain up to 16% of urinary stone disease in pediatric patients.

IgA nephropathy:

  • Patients with isolated microscopic hematuria due to IgA nephropathy or thin basement membrane nephropathy typically only require monitoring for CKD progression with blood pressure and urine checks.

  • Although asymptomatic, these patients are at higher risk for ESKD than the general population.

  • For rarer causes (e.g., nutcracker syndrome), consider referral to a specialist (vascular surgeon) at a tertiary care center.

Research

Landmark clinical trials and other important studies

Research

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

Raune T et al. for the STOP-IgAN Investigators. N Engl J Med 2015.

IgA nephropathy has a wide clinical presentation, and the use of immunosuppression is widespread but controversial. In this multicenter, open-label, randomized control trial, the addition of immunosuppressive therapy to intensive supportive care in patients with high-risk IgA nephropathy did not significantly improve the outcome, and during the 3-year study phase, more adverse effects were observed among the patients who received immunosuppressive therapy, with no change in the rate of decrease in the glomerular filtration rate (eGFR).

[Image]
Persistent Asymptomatic Isolated Microscopic Hematuria in Israeli Adolescents and Young Adults and Risk for End-Stage Renal Disease

Vivante A et al. JAMA 2011.

This study assessed healthy individuals with microscopic hematuria at the time of enrollment to the Israeli military. After cross-referencing the end-stage kidney disease registry, patients who were otherwise healthy with asymptomatic microscopic hematuria had a higher risk of developing signs of ESKD compared to the general population. Thus, one can conclude that the diagnosis of “benign familial hematuria” is a misnomer.

[Image]
Hypercalciuria in Children with Hematuria

Stapleton FB et al. N Engl J Med 1984.

This study showed that determination of urinary calcium excretion is warranted in the routine evaluation of children with hematuria.

[Image]
Frequency and Etiology of Gross Hematuria in a General Pediatric Setting

Ingelfinger JR et al. Pediatrics 1977.

This study examined 128,395 patient visits over 24 months and demonstrated that among 158 cases of gross hematuria (1.3/1000 visits), 56% had readily apparent causes of hematuria, including infection such as UTI. Only 9% of cases had a glomerular cause of hematuria.

[Image]

Reviews

The best overviews of the literature on this topic

Reviews

Hematuria and Proteinuria in Children

Viteri B and Reid-Adam J. Pediatr Rev 2018.

[Image]
IgA Nephropathy

Wyatt RJ and Julian BA. N Engl J Med 2013.

[Image]